Tackling Drug Resistance in Cancer Treatment – Stefanie Flückiger
We Are ETH
Overcoming Cancer: Drug Resistance and Innovation
This chapter examines the complexities of cancer treatment, particularly focusing on the issue of drug resistance that arises after initial successes with therapies like BRAF inhibitors for melanoma. It explores the mechanisms by which cancer cells adapt and evade treatments, leading to tumor regrowth, while also discussing the transition from research to the development of innovative cancer therapies. Additionally, the chapter highlights the founding of a biotech company, emphasizing collaboration, mentorship, and the personal academic journeys that shape scientific careers.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
